Last month, Hutchison China MediTech (ticker: HCM) CEO Christian Hogg gave the following enlightening interview to CNBC (transcript below). I'll publish more on HCM soon:
Saturday, December 23, 2017
Saturday, December 16, 2017
Chromadex Management Makes its Case (CDXC)
At first glance, most investors would likely pass on Chromadex (ticker: CDXC). The stock has been largely flat for years.
Subscribe to:
Posts (Atom)